Banglapress Desk: Haridwar-based Patanjali Yogpith, a company of Yoga Guru Baba Ramdev and his aide Acharya Balkrishna, on Tuesday launched an ayurvedic medicine that they claimed could treat Covid-19.
The Yoga guru said the medicine titled ‘Coronil and Swasari’ is not an immunity booster but a sure-shot cure.
“The medicine has healed a Covid-19 patient within 3-7 days. Our clinical trials have proved the efficacy of the medicine to be 100%. We are proud to present the first-ever ayurvedic medicine for the viral infection the world is grappling with. The medicine has been prepared with the combined efforts of Patanjali Research Centre and Nizam I Institute of Medical Sciences,” said the yoga guru at a press conference in Haridwar in the presence of his aide and chief executive officer of the company Acharya Balkrishna. Ramdev added that the company conducted two trials of these medicines.
He said the first controlled clinical study took place in cities such as Delhi and Ahmedabad. “Under this study, a total of 280 patients had recovered. The medicines checked the complications and there was no loss of lives,” he added.
Reacting to the claims, the AYUSH ministry asked Patanjali to provide at the earliest details of the name and composition of the drug. Patanjali has also been asked to submit the details of the sample size, sites and hospitals where its research study was conducted, and also share the ethics panel clearance.
The ministry froze the advertisement of the new drug too until the “issue” is examined. It said the advertisements of Patanjali’s alleged drugs are regulated under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. Patanjali had priced its Corona kit at Rs 545 and said it could be used for 30 days.
At the launch, Acharya Balkrishna said the kit will be made available in Patanjali stores within a week. “We are also planning to launch an android mobile application which will come handy in delivering of the Corona kits at doorsteps,” he had said, adding that necessary approvals for conducting the trials of medicine on patients had been taken from the authorities concerned.
BP/SM
